Malaria—a parasite vector-borne disease—is a global health problem, and Plasmodium
falciparum has proven to be the deadliest among Plasmodium spp., which causes malaria in …

Plasmodium falciparum malaria still remains a major global public health challenge with
over 220 million new cases and well over 400,000 deaths annually. Most of the deaths occur …

Background Tumour necrosis factor-alpha (TNF-α) levels are reportedly altered during
malaria. In this systematic review and meta-analysis, we aimed to collect and compare data …

Clinical immunity against Plasmodium falciparum infection develops in residents of malaria
endemic regions, manifesting in reduced clinical symptoms during infection and in …

The past decade has witnessed dramatic decreases in malaria‐associated mortality and
morbidity around the world. This progress has largely been due to intensified malaria control …

The number of patients infected with simian malaria is gradually increasing in many
countries of Southeast Asia and South America. The most important risk factor for a zoonotic …

Transforming growth factor-β (TGF-β) is important in the pathophysiology of malaria, but its
role in acute and severe malaria is largely unknown. As a result, this study used a meta …

Invasive nontyphoidal Salmonella (iNTS) infections are commonly associated with
Plasmodium falciparum infections, but the immunologic basis for this linkage is poorly …

Severe malaria occurs most in young children but is poorly understood due to the absence
of a developmentally‐equivalent rodent model to study the pathogenesis of the disease …

Throughout the evolution humans co-exist with plethora of parasites. Host-parasite
interactions are extraordinary complex and may result in elimination of the parasite …